CIK 0001857044
- Non-accelerated filer
- Smaller reporting company
Indaptus Therapeutics, Inc.
Sign in to watch- Ticker
- INDP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863158720
- Phone
- +1 646-427-2727
- Business address
- 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
- Former names
- Intec Parent Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2024-06-06 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2023-05-25 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +12,500 | 12,500 | ||
| 2022-09-30 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +13,750 | 13,750 | ||
| 2021-12-01 | Gilbert Mark John Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 1 of 1 · 5 trades